IL77188A0 - Pharmaceutical compositions for the treatment of acquired immune deficiency syndrome and analogous syndromes - Google Patents

Pharmaceutical compositions for the treatment of acquired immune deficiency syndrome and analogous syndromes

Info

Publication number
IL77188A0
IL77188A0 IL77188A IL7718885A IL77188A0 IL 77188 A0 IL77188 A0 IL 77188A0 IL 77188 A IL77188 A IL 77188A IL 7718885 A IL7718885 A IL 7718885A IL 77188 A0 IL77188 A0 IL 77188A0
Authority
IL
Israel
Prior art keywords
treatment
syndromes
immune deficiency
deficiency syndrome
acquired immune
Prior art date
Application number
IL77188A
Other versions
IL77188A (en
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of IL77188A0 publication Critical patent/IL77188A0/en
Publication of IL77188A publication Critical patent/IL77188A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

1. Use of an alkali metal salt and/or alkaline earth metal salt and/or ammonium salt of the heteropolyanion (NaSb9 W21 O86)**18-, optionally in a hydrated form, for manufacturing a medicinal composition intended for the treatment of acquired immune deficiency syndrome (AIDS) and similar syndromes.
IL77188A 1984-12-03 1985-11-29 Pharmaceutical compositions containing hpa23 for the treatment of acquired immune deficiency syndrome and analogous syndromes IL77188A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67824084A 1984-12-03 1984-12-03

Publications (2)

Publication Number Publication Date
IL77188A0 true IL77188A0 (en) 1986-04-29
IL77188A IL77188A (en) 1989-03-31

Family

ID=24721989

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77188A IL77188A (en) 1984-12-03 1985-11-29 Pharmaceutical compositions containing hpa23 for the treatment of acquired immune deficiency syndrome and analogous syndromes

Country Status (6)

Country Link
EP (1) EP0185584B1 (en)
JP (1) JPS61227525A (en)
AT (1) ATE37142T1 (en)
AU (1) AU589148B2 (en)
DE (2) DE3542165A1 (en)
IL (1) IL77188A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU607709B2 (en) * 1986-08-07 1991-03-14 Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg A micelle containing a hydrophobic pharmaceutically active substance
JP2707252B2 (en) * 1987-08-03 1998-01-28 利博 山瀬 Antiviral agent
WO1990006756A1 (en) * 1988-12-16 1990-06-28 Terumo Kabushiki Kaisha Antiviral agent
JP2993674B2 (en) * 1989-02-01 1999-12-20 利博 山瀬 Anti-acquired immunodeficiency syndrome virus agent
JPH0334931A (en) * 1989-06-30 1991-02-14 Hokkaido Togyo Kk Anti-retrovirus agent
DE4302053C1 (en) * 1993-01-26 1994-06-30 Gunther Dr Kuemel Synergistic compsn. for preventing HIV infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245374B1 (en) * 1973-07-27 1977-02-25 Anvar
FR2334366A2 (en) * 1975-12-10 1977-07-08 Anvar 9-Antimonic-(21)-tungsto-sodate heteropolyanions - pref. as the ammonium or metal salts are antivirals synergistic with interferon, active against leukaemia and sarcoma viruses
GB1573002A (en) * 1975-12-10 1980-08-13 Anvar Antiviral agent
FR2372633A2 (en) * 1976-12-03 1978-06-30 Anvar COMPOUND OF HETEROPOLYANIONS CONTAINING TUNGSTENE COMBINED WITH ANTIMONY, THEIR OBTAINING AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
DE3564907D1 (en) 1988-10-20
AU589148B2 (en) 1989-10-05
EP0185584A1 (en) 1986-06-25
JPH0262533B2 (en) 1990-12-26
IL77188A (en) 1989-03-31
DE3542165A1 (en) 1986-07-10
JPS61227525A (en) 1986-10-09
EP0185584B1 (en) 1988-09-14
ATE37142T1 (en) 1988-09-15
AU5058085A (en) 1986-07-17

Similar Documents

Publication Publication Date Title
OA08656A (en) Aqueous polsaccharide compositions.
OA08711A (en) Improved fibrinolytic composition.
EP0137010A4 (en) Naphthyl or tetrahydronaphthyl-substituted naphthoic acid and de rivates.
IL65918A0 (en) Water-soluble benzothiazine dioxide salts and pharmaceutical compositions containing them
DE68901737D1 (en) ALKYLSULPHONYLPERCARBONIC ACIDS AND THE BLASTING AND CLEANING COMPOSITIONS CONTAINING THEM.
GB2178422B (en) Prosthesis formed from water-soluble phosphate glass.
ZA879011B (en) Variants of hirudin,their use and their preparation
IL77188A0 (en) Pharmaceutical compositions for the treatment of acquired immune deficiency syndrome and analogous syndromes
NZ208669A (en) Human calcitonin 2, and pharmaceutical compositions
PH24343A (en) Nitrification-inhibiting agent
GB2208620B (en) Seals between ceramic articles or between ceramic articles and metal articles.
ZA858195B (en) 1,2,4-triazolo-carbamates and the acid addition salts thereof,processes for preparing them and pharmaceutical compositions
EP0107693A4 (en) 2,3,4-trinor-1,5-inter-m-phenylene-prostacyclin-i2 analogues, process for the preparation thereof and pharmaceutical compositions containing the same.
HUT37887A (en) Disinfecting compositions and process for the preparation thereof
EP0338092A4 (en) Anti-hiv agent.
NZ214088A (en) 1,3-diazoles and pharmaceutical compositions
NZ234369A (en) 6-(naphthalenylethyl)-4-hydroxy-pyran-2-one derivatives and the 3,5-dihydroxyheptanoates; pharmaceutical compositions
IL77426A (en) 2,6-dimethyl-8alpha-pivaloyl-amino-9,10-didehydro-ergoline,its production and pharmaceutical compositions containing it
GB2171701B (en) 8-oxo-2-oxa-1-azabicyclo(4.2.0)octane-3-carboxylic acids
EP0137436A3 (en) Oral hygiene compositon
IL85254A0 (en) 14,15-substituted lanosterols and pharmaceutical compositions containing them
IT7925638A0 (en) PACKAGING PROCEDURE FOR POWDERED OR GRANULED PRODUCTS IN SOFT PACKAGING AND INSTALLATION FOR THE IMPLEMENTATION OF THIS PROCEDURE.
ES8401320A1 (en) Antibronchospastic water-soluble pharmaceutical compositions
DE3166701D1 (en) 3-amino-5-substituted-6-halo-n-(3,4-dihydro- or 4,4-disubstituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides, process for preparing and pharmaceutical compositions containing the same
Dawson Friendship and the theory of positive disintegration